Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NeuroMetrix Inc NURO

Healthcare Medical Devices
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two... see more

Recent & Breaking News (NDAQ:NURO)

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ML, PWOD, NURO, CARA on Behalf of Shareholders

PR Newswire January 7, 2025

NEUROMETRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeuroMetrix, Inc. - NURO

Business Wire January 6, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, NURO, PWOD, CARA on Behalf of Shareholders

PR Newswire December 23, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ML, NURO, CARA on Behalf of Shareholders

Accesswire December 20, 2024

$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger - PWOD, CARA, NURO, VOXX

Accesswire December 19, 2024

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating NeuroMetrix, Inc. Buyout

Newsfile December 18, 2024

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of NeuroMetrix, Inc. - NURO

PR Newswire December 18, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ZUO, BMTX on Behalf of Shareholders

PR Newswire December 18, 2024

Kuehn Law Encourages PWOD, NURO, BHLB, and BRKL Investors to Contact Law Firm

PR Newswire December 18, 2024

NURO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NeuroMetrix, Inc. Is Fair to Shareholders

Business Wire December 17, 2024

NeuroMetrix to be Acquired by electroCore

GlobeNewswire December 17, 2024

NeuroMetrix Reports Q3 2024 Business Highlights

GlobeNewswire November 5, 2024

NeuroMetrix Reiterates its Review of Strategic Alternatives

GlobeNewswire August 13, 2024

NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options

GlobeNewswire August 6, 2024

NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call

GlobeNewswire July 31, 2024

NeuroMetrix Reports Q1 2024 Business Highlights

GlobeNewswire May 15, 2024

NeuroMetrix Announces Steps Taken to Enhance Shareholder Value

GlobeNewswire April 19, 2024

NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy

GlobeNewswire March 14, 2024

NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia

GlobeNewswire March 13, 2024

Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired

Accesswire March 12, 2024